Structured intelligence coverage

Structured records are temporarily unavailable. The published profile and its source ledger remain accessible.

Identity checks do not refresh the age of governance evidence. Open a record for its source date and review state.

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
11 current organization shown on this profile
Board positions
11 supported by public sources, 0 supplied by the profile owner
Committee roles
4Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Joel I. Klein has worked for more than 50 years in private industry and government with significant experience in senior policy making and executive roles. He served as Chancellor of the New York City Department of Education from 2002-2010 and held various positions at News Corporation. He is currently CEO of Retromer Therapeutics Corp., a biotech start-up.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Lead Independent Director

BXP, Inc. (NYSE: BXP)

Jan 1, 2013 – Present

Independence: Independent

Source effective: 2026-04-10 · Observed: 2026-05-03T01:00:02.843+00:00

confirmedView source

Governance

Board appointments, committee responsibilities and disclosed relationships.

Committee appointments across companies · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Lead Independent Director

BXP, Inc.

2013-01-01 · current

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

BXP, Inc.

Open BXP, Inc. profile →

Lead Independent Director at BXP, Inc.

2013-01-01 → End not stated

current · source reported

Observed: 2026-09-25

BXP, Inc.BXP, Inc.Joel I. Klein

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

  • BXP, Inc.

    Lead Independent Director

    Verified public fact

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec ProxyPublic profile sourceSupports Lead Independent Director at BXP, Inc. (NYSE: BXP).Open sourceSource 2 · Sec FilingBXP DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Executive company, Executive title, Cybersecurity experience, Technology background.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:joel-i-klein
Record version
public-0

Published evidence records

4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Open source

    sec proxy · Source published: Apr 10, 2026 · Retrieved: May 3, 2026

    Supports 1 claim
    • Professional Role: Lead Independent Director at BXP, Inc. · Claim reviewed: May 15, 2026

  2. BXP DEF 14A director slate

    sec filing · Source published: Apr 9, 2025 · Retrieved: May 15, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Board role: Board role: Lead Independent Director · Claim reviewed: May 15, 2026
    • Committee assignments: Committee assignments: Compensation, Audit, Nominating/Governance, Sustainability · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Retromer Therapeutics Corp. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Chief Executive Officer · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  3. BXP, Inc. director board source

    sec filing · Source published: Apr 9, 2025 · Retrieved: May 3, 2026

    Supports 3 claims
    • Board independence: Independent director · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of BXP, Inc. · Claim reviewed: May 3, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 3, 2026

  4. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of BXP, Inc. · Claim reviewed: May 3, 2026

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · Source reportedAI and ML experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Board independence · Source reportedIndependent director1 source
Verification
Source reported
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · CorroboratedServes on the board of BXP, Inc.Supported by 2 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board role · Source reportedBoard role: Lead Independent Director1 source
Verification
Source reported
Confidence
92%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedNo committee assignment disclosed in the cited filing1 source
Verification
Source reported
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Committee assignments · Source reportedCommittee assignments: Compensation, Audit, Nominating/Governance, Sustainability1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Cybersecurity experience · Source reportedCybersecurity experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive company · Source reportedExecutive at Retromer Therapeutics Corp.1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive title · Source reportedExecutive title: Chief Executive Officer1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Technology background · Source reportedTechnology background: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

View all sources4 records
  1. https://www.sec.gov/Archives/edgar/data/1037540/000103754026000010/bxp-20260410.htm

    Sec Proxy · Tier not stated · Reviewed May 3, 2026

    Supports: Lead Independent Director at BXP, Inc. (NYSE: BXP)

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Executive company · Executive title · Cybersecurity experience · Technology background

  3. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Board independence

  4. https://www.sec.gov/Archives/edgar/data/1037540/000103754026000010/bxp-20260410.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership